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Abstract
Purpose: To develop a novel colorimetric assay method for mefenamic acid capsules.
Method: The new method (aromatic ring derivatization technique) is based on a diazo coupling
reaction using diazotized 4-amino-3,5-dinitrobenzoic acid (ADBA) as a chromogenic derivatizing
reagent. 
Result: Optimization studies showed that the coupling reaction is very fast and completed in
less than 1 minute.  A 1:1 drug to reagent stoichiometric ratio was obtained for the azo dye
formed. The azo adduct formed exhibits bathochromic shift with absorption maximum (λ max) at
490 nm, which was selected as the analytical wavelength. Lower limit of quantitation of
mefenamic acid was 1 µ g/ml. The assays were linear over the concentration range of 1 - 6
µ g/ml and reproducible. This new method has been successfully applied in the assay of
mefenamic acid capsules with accuracy similar to the official (B.P) titrimetric method of assay
(p>0.05) and has the advantages of speed, high sensitivity, lower limit of detection and can be
automated. 
Conclusion: The method developed could find application in in-process quality control of
mefenamic acid capsules.
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Introduction
Mefenamic acid is a non-steroidal anti-
inflammatory drug (NSAID) which has
analgesic, anti-inflammatory and antipyretic
actions. It is been used for the relief of mild to
moderate pain. It is also indicated for the
treatment of rheumatoid arthritis1, primary
dysmenorrhea2 and periodontitis3. The official
method for the assay of the pure drug and the
capsules is titrimetry, using sodium hydroxide
as titrant and phenol red as indicator4, 5. A
variety of methods have been used for the
determination of the drug in biological fluids.
Determination in the serum has been carried
out with high performance l iquid
chromatography (HPLC) with UV detection
and spectrofluorimetry7. Determination in the
blood has been carried out with HPLC with
photodiode array detector and gas
chromatography (GC) with flame ionisation
detector8. Determination in urine was
reportedly done by HPLC9.
Trends in pharmaceutical analysis and
compendial assay methods reflect increasing
replacement of time-honoured classical
methods of analysis with modern, more
sophisticated instrumental methods,
especially HPLC. However, the high
acquisition and maintenance cost of this
equipment makes adoption of assay methods
based on them rather inconvenient, especially
in poor-resource economies. This often
warrants the use of an alternative method.
The British Pharmacopoeia gives allowance
for the use of an alternative method for any
test or assay, if it is known that the method
used will be of equivalent accuracy with the
prescribed assay method4.
Colorimetry as an analytical technique
became obsolete with the advent of scanning
spectrophotometers. By means of the
monochromator, discrete wavelength interval
in the ultraviolet, visible and near infra-red
region can be isolated easily on
spectrophotometers. However, the simpler
architecture of digital colorimeters using built-
in gelatin filters and drop-in interference filters
means initial acquisition and maintenance
costs are much lower. Vastly improved
electronics, integrated circuitry and
microprocessor technology incorporated into
the design of modern colorimeters now
produce two to three decimal place resolution.
In addition, they have interfacing capabilities
with computers. These attractive features led
to a resurgence of interest in colorimetric
assay of pharmaceuticals. Modern colorimetry
provides a unique combination of high
technology and low cost in analytical
methodology; it shares the typical merits of
instrumental methods, especially, faster
handling of large sample throughput10.
In this paper, we report a novel colorimetric
assay of mefenamic acid in pharmaceutical
dosage forms using a newly developed
chromogenic derivatizing reagent. The
reagent ,  d iazo t i zed  4 -amino-3,5-
dinitrobenzoic acid (ADBA), is a dinitrophenyl
arenediazonium ion, which functions via an
aromatic ring derivatization technique based
on diazo coupling reaction 11-13.
Experimental
Chemicals and Reagents
Pons tan  capsu les  (Pa rk e -Dav i s ,
Istanbul,Turkey), Mefacap® capsules
(Malaysia Pharmaceutical Factory, Malaysia),
mefenamic acid crystals (isolated and purified
in our laboratory), ethanol, ethyl acetate,
glacial acetic acid, concentrated sulphuric
acid, sodium nitrite, potassium hydrogen
phthalate, sodium hydroxide pellets, phenol
red crystals, dried magnesium sulphate (all
are analytical reagents from BDH, UK).
Equipment
UV/visible spectrophotometer (Unicam
Aurora, Helios Scan, software v 1.1), digital
colorimeter, model 6051 (Jenway, U.K),
Mettler balance H80 (U.K.), ultrasonic bath
(Langford, U.K).
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Method
The solution of ADBA in concentrated
sulphuric acid was diazotized with sodium
nitrite as previously reported11.  Sodium
hydroxide (0.1 M) was prepared and
standardized as previously described5.
Mefenamic acid stock solution was ma de by
dissolving mefenamic acid crystals (10mg) in
hot (about 70  oC) glacial acetic acid (6 ml)
with stirring. The solution was allowed to cool
and the volume was then made up to 10 ml in
a volumetric flask by adding fresh glacial
acetic acid.
In order to determine a suitable analytical
wavelength for the reaction product, two
critical response parameters (temperature and
reaction time) were optimized using the
method of steepest ascent14. Aliquot of
mefenamic acid stock solution (50 µl) was
added to the reagent solution (500 µl) in a test
tube and the reaction mixture was mixed in a
vortex mixer for 10 sec followed by incubation
in turn at 30 oC and 50 oC for 5 minutes and 20
minutes, respectively. Similar experiments
were performed at 60 oC and 80 oC. Each
determination was done in duplicate. The
reaction was terminated by addition of ice-cold
water (5ml) to the reaction mixture kept in ice-
bath. Aqueous solution was extracted with
ethyl acetate (10 ml) and kept in a vial
wrapped with aluminium foil. A blank reagent
solution was prepared in a similar way but
replacing the stock solution with glacial acetic
acid. The absorption spectrum of the reaction
mixture extract was determined against the
absorption spectrum of the blank reagent
e x t r a c t  u s i n g  t h e  U V / v i s i b l e
spectrophotometer and the optimal absorption
wavelength, 490nm, was selected for sample
analysis.
The optimal reaction time was determined by
adding aliquot of mefenamic acid stock
solution (50 µl) in turn to the reagent solution
(500 µl) in six tubes. Coupling reaction was
carried out by incubation at 30 oC for 0, 1, 2, 3,
4 and 5 min. Ethyl acetate extracts of the
reaction mixtures was prepared as usual after
each reaction time and the absorbance was
measured at 490 nm on the digital
colorimeter. An optimal reaction time was
then determined as the time corresponding to
the maximal absorption of the samples. All
determinations were done in duplicate.
The best extraction method was determined
by extracting the reaction mixture (50 µl of
mefenamic acid stock solution and 500 µl of
reagent solution, mixed for 10 seconds
followed by mixing with 5 ml of ice-cold water
to terminate the reaction) with ethyl acetate
(10 ml or 3 ml in 2 portions followed by 4 ml).
Combined extracts of ethyl acetate were dried
over anhydrous magnesium sulphate and
then filtered in a glass pasteur pipette
plugged with cotton wool into a 10 ml
volumetric flask. The volume was made up
with fresh ethyl acetate and absorbance of the
sample determined at 490 nm. This
procedure was carried out in triplicates.
Photostability of the azo adduct in ethyl
acetate
Standard test solutions containing 5 µg/ml
were prepared in six sample vials. Three of
the vials were wrapped with aluminium foil,
while the other three were left unwrapped.
Both sets were kept on the laboratory bench.
The absorbance reading of the extracts at
490 nm were taken at 30 minutes interval for
a period of three hours. 
Stoichiometric ratio of drug-reagent adduct
formation
Equimolar solutions (9.18x10-4 M) of the
reagent and the drug stock solution were
prepared using the procedures described
above. In five different test tubes, 0, 2.5, 5.0,
7.5 and 1.0 ml of the reagent solution were
added, respectively. Each tube was then
made up to 1.0 ml with the drug stock
solution. A series of blank determination were
carried out in which the volume of the drug
stock solution was replaced with glacial acetic
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acid. The mixture was mixed in a vortex mixer
for 10 sec and the extraction carried out
afterwards as usual. The absorbance was
measured at 490 nm against the blank and
the absorbance values obtained were plotted
against the mole fraction of the reagent
solution. Each determination was carried out
in duplicate. 
Assay of dosage form
The amount of mixed contents of 20 capsules
equivalent to 10 mg of mefenamic acid were
weighed and dissolved in hot  (about 70 oC)
glacial acetic acid and mixed in an ultra-
sonicator for 5 min. The solution was allowed
to cool and filtered through a cotton wool plug
into a 10 ml volumetric flask. The volume was
then made up with fresh glacial acetic acid,
rinsing the filter aid in the process. An aliquot
of the drug stock solution (50 µl) was added to
the reagent solution (500 µl). The mixture was
then mixed in a vortex mixer for 10 sec and
extracted with 10 ml of ethylacetate as
described above and the absorbance
measured at 490 nm. Content of the
mefenamic acid capsules were then
determined by interpolation from calibration
lines. The sample analysis was repeated
using the B.P5 procedure. Two formulations of
mefenamic acid (Ponstan and Mefacap)
were used in the assays. 
The assay results using the two methods (the
method being reported and the B.P. method)
were compared using the Student’s t-test. A 2-
tailed probability values (p-value) less than or
equal to 0.05 at 95% confidence interval was
considered to be significant.
Validation of methods.
Calibration lines using standard solutions of 0,
2.5, 5, 10, 20, 40 and 80 µg/ml mefenamic
acid were carried out using the optimal
analytical conditions as described above.
Linear regression analysis was used to
calculate the slope, intercept and the
correlation coefficients (r2) of each calibration
line. The assay precision and accuracy were
determined as previously described14. The
limit of detection was computed as previously
described as the analyte concentration giving
a signal equal to the blank signal plus three
standard deviations of the blank15.
Results
The spectrum of mefenamic acid in ethyl
acetate showed two absorption maxima at
280 nm and 350 nm (Figure 1). Coupling
reaction of mefenamic acid and reagent
solution formed a reddish-pink adduct under
all coupling conditions tried and the spectrum
of the adduct indicated bathochromic shift,
with an optimal peak at 490 nm. The blank
reagent also has peaks at 260 nm, 340 nm
and 430 nm (Figure 2). Absorbance of the
adduct was highest at 30oC and 5 min
reaction time (Figure 3). There was no
significant change in absorbance over the
reaction time investigated (Figure 4).  
Comparison of the single and multiple
extraction process revealed that multiple
Figure 1: Absorption spectrum of mefenamic acid in
ethyl acetate
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extraction offered no advantage as the
extraction of the adduct with a single lot of 10
ml ethyl acetate gave mean absorbance
valueof 0.34 ± 0.01 while the multiple
extraction process gave mean absorbance
value of 0.33 ± 0.01 at 490 nm. Maximum
absorbance of the adduct was obtained at a
mole fraction of 0.5 for the reagent solution
(Figure 5) and the absorbance was found to
 decrease at a lower or higher mole fractions.
The azo adduct formed by the coupling
reaction was found to be stable to light over a
period of 3 h.
Comparative analysis of two brands of
mefenamic acid capsules by the official
titrimetric method and the new method is
shown in Table 1.  There was no significant 
Figure 3: Optimization of coupling reaction temperature
(----, 5 min;  20 min)
Figure 2: Overlaid absorption spectra of blank reagent
(  ) and coupling reaction  mixture (test, ------) extract Figure 4: Optimization of reaction time at 30 oC
Figure 5: Determination of stoichiometric ratio of drug-
reagent adduct
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Azo adduct
difference between the titrimetric method of
B.P. and the method being reported (p >
0.05). 
Assay regression equation for the calibration
line under the optimal conditions is y =
0.0646x + 0.024 with r2 of 0.9875. The limit of
detection was determined as 0.96 µg/ml. The
overall recovery of extracted samples is
101.88 ±1.37% and the coefficient of variation
is 1.36% (Table 2).  Repeatability of extraction
was found to be better for the larger analyte (6
µg/ml) when compared to lower quantities of
the analytes.
Discussion
Diazo coupling of mefenamic acid with the
reagent produced bathochromic  shift in the
absorption spectm of the reaction mixtures
(Figure 2) relative to the absorption spectrum
of mefenamic acid alone (Figure 1). This is
indicative of the formation of an azo dye
(Scheme 1). Mefenamic acid has two
aromatic rings (A and B) joined by an amino
bridge. The para position to the amino group
is favoured for coupling on both rings,
considering the combined directing influence
of the ring substituents toward electrophilic
aromatic substitution reaction. However, the
para position on ring B is more sterically
hindered thus making ring A the most likely
point of attack. The very fast reaction
observed is due to the strong ring activating
effect of the amino group and the meta
directing influence of the carboxyl group. Both
substituents favour the same point of attack.
The peak at 490nm was selected as the
analytical wavelength because at this
wavelength, the difference in absorptivity
between the blank reagent and the adduct is
Table 2: Three-day assessment of accuracy and precision of the new method of assay of mefenamic acid
Concentration
(µg/ml)
              Day 1             Day 2           Day 3        
Mean ±s.d*        RSD Mean±s.d*          RSD Mean±s.d *             RSD
2.0 100.10±4.47 4.47 102.68 ±4.47 4.35 102.68 ±4.47 4.35
4.0 100.36± 2.23 2.22 101.65 ±2.34 2.3 101.65± 2.33 2.19
6.0 100.45± 1.49 1.48 99.59± 2.58 2.59 98.73 ±1.49 1.51
*n = 9; Regression equation: Y=0.0646x+0.024 (r2=0.9875); Between-day statistics: =100.88± 1.37% (mean ± s.e.m)
RSD (of s.e.m) = 1.36%
Table 1: Assay of mefenamic acid capsules by official
method and the new method
Dosage form brand
Mean±S.D
    ADBA*                B.P
Ponstan® 101.70±1.43 101.80±0.12
Mefacap® 100.16±1.44 100.43±0.15
* n = 8,  = n = 5, Official range = 95.0 –105%(B.P. 1998),
p< 0.05 is taken as significant.
ADBA = New colorimetric assay method; B.P. = Official
titrimetric method.
Scheme 1: Coupling reaction between diazotized ADBA
and mefenamic acid
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maximal16. Incubation at elevated temperature
was found to be unnecessary, because
thermal degradation led to a lower detector
response at temperatures higher than 30 oC
(Figure 3). Incubation at even 30 oC for any
length of time was shown to be unnecessary.
The reaction is shown to be so fast as to be
completed in less than 1 min. The absorbance
of the test extract prepared immediately after
mixing in a vortex mixer for 10seconds is the
same as the absorbance after 5 min of
incubation at 30 oC (Figure 4).
In theory, multiple extraction with organic
solvents guarantees complete extraction than
single extraction procedure. However,
because of the low concentrations involved
(microgram quantities) and the partition
coefficient of the adduct in the solvent system
employed, single extraction is as efficient as
multiple extraction. In addition, time is gained
in the overall analysis with single extraction.
For a constant total concentration of two
interacting species, the complex is at its
greatest concentration at a point where the
two species are combined in the ratio in which
they occur in the complex17. The plot of
absorbance against the mole fraction of the
reagent exhibited a change of slope with a
maximum absorbance at a mole fraction of
0.5 and decreasing absorption as the value of
the mole fraction deviate from 0.5 (Figure 5).
The implication of this is that better
absorbance of the adduct will be obtained at
equimolar concentrations of the mefenamic
acid sample and the reagent.  This also
signifies that the optimal coupling reaction
conditions routinely employed forms the azo
dye by a 1:1 drug to reagent stoichiometric
ratio as depicted in Scheme 1. 
Classical methods are typically more precise
than instrumental methods10, as such, the
official titrimetric method was more precise
than the colorimetric method reported here.
However, the new method is of equivalent
accuracy to the official method (Table 2).
Conclusion
A novel colorimetric assay method for
mefenamic acid capsules based on a very
fast diazo coupling reaction of the drug with
diazotized ADBA has been developed. The
new method was shown to be of equivalent
accuracy with the official (B.P) titrimetric
method. It has the advantages of speed , high
sensitivity and lower limit of detection. The
new method can also be easily automated by
interfacing the digital colorimeter with
computers. It could find application in in-
process quality control of mefenamic acid
capsules.
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